New Phase 3 data with aprocitentan for patients with resista

New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023

New Phase 3 data with aprocitentan for patients with resistant hypertension has been presented at the American Society of Nephrology Kidney Week 2023

streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Australia , Switzerland , United States , Japan , Allschwil , Switzerland General , Dublin , Ireland , Swiss , American , America , Clozelm Aprocitentan , Arterioscler Thromb Vasc , J Physiol Pharmacol , Alberto Gimona , Andrewc Weiss , Irvine Page , Markus Schlaich , George Bakris , American Society Of Nephrology , American Society Of Hypertension , Idorsia Pharmaceuticals Ltd , University Of Chicago Medicine , Hypertension Center , University Of Chicago School Medicine , American College Of Clinical Pharmacology , National Kidney Foundation , National Committee , Clinical Practice Guideline Committee , Swiss Exchange , American Heart Association , Editor Or Co , American Diabetes Association , Idorsia Ltd , Bp Council , Head Of Global Clinical Development Idorsia , Head Of Investor Relations Corporate Communications , American Society , Kidney Week , Late Breaking Science , Scientific Sessions , Comprehensive Hypertension Center , Chicago School , Global Clinical Development , Risk Evaluation , Mitigation Strategy , African American , North America , Certified Hypertension Specialist , Mayo Clinic , Diabetic Kidney Disease Progression , Cardiorenal Advisory Board , Joint National Committee , Blood Pressure , Diabetes Guideline , Pressure Consensus Report , Resistant Hypertension Consensus , American College , Clinical Pharmacology , Hypertension Section , Diabetes Care , Rev Pharmacol , Factor Collaboration , Thromb Vasc Biol , Clin Hypertension , Vice President , Investor Relations , Pharmaceuticals Ltd ,